The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of...

Area of Science:

• Genetics
• Developmental Biology
• Clinical Medicine

Background:

• RASopathies are a group of developmental disorders with overlapping clinical features.
• These syndromes share common genetic underpinnings related to the RAS/mitogen-activated protein kinase (MAPK) pathway.
• Key features include craniofacial abnormalities, cardiac defects, skin issues, intellectual disability, and cancer predisposition.

Purpose of the Study:

• To review the clinical and molecular characteristics of selected RASopathies.
• To provide an overview of syndromes like Noonan syndrome, Costello syndrome, and neurofibromatosis type 1.
• To highlight the role of the RAS/MAPK pathway in these developmental disorders.

Main Methods:

• Literature review of clinical and genetic studies on RASopathies.
• Synthesis of information on the phenotypic spectrum of included syndromes.
• Analysis of molecular mechanisms associated with RAS/MAPK pathway gene mutations.

Main Results:

• RASopathies present with diverse yet overlapping phenotypes, influenced by specific gene mutations.
• Germline mutations in RAS/MAPK pathway genes are the causative agents.
• Selected syndromes like Noonan syndrome, CFC syndrome, and NF1 share common pathway dysregulation.

Conclusions:

• Understanding the clinical and molecular features of RASopathies is crucial for diagnosis and management.
• The RAS/MAPK pathway is central to the pathogenesis of these developmental syndromes.
• Further research into specific RASopathies can improve patient outcomes.